• Publications
  • Influence
Varenicline: for smoking cessation.
Varenicline, a partial agonist of alpha4beta2 nicotinic acetylcholine receptor (nAChR), is the most recently approved drug for smoking cessation. Despite the availability of effective treatments forExpand
  • 30
  • 2
  • PDF
Evaluation of Antidiabetic Activity of Ginkgo Biloba in Streptozotocin Induced Diabetic Rats
The objective of the study was to evaluate the antidiabetic activity of Ginkgo biloba and to probe into its mechanism of action. Methods. Albino wistar rats with streptozotocin induced diabetes wereExpand
  • 29
Ramelteon: a melatonin receptor agonist for the treatment of insomnia.
Ramelteon is a novel MT1 and MT2 melatonin receptor selective agonist recently approved for the treatment of insomnia characterized by difficulty in sleep onset. It is a nonscheduled drug since itExpand
  • 4
  • PDF
Efficacy and tolerability of trandolapril in mild to moderate hypertension--a double blind comparative clinical trial with enalapril in Indian population.
Several large scale clinical trials have demonstrated that angiotensin converting enzyme inhibitors offer cardiovascular and renal protection independent of their effects on systolic BP. TrandolaprilExpand
  • 3
  • PDF
Efficacy and tolerability of fixed-dose combination of simvastatin plus ezetimibe in patients with primary hypercholesterolemia: Results of a multicentric trial from India.
OBJECTIVE To compare the efficacy and safety of fixed-dose combination (FDC) of simvastatin and ezetimibe vs simvastatin monotherapy in Indian patients with primary hypercholesterolemia. METHODSExpand
  • 3